Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-025643
Filing Date
2025-08-27
Accepted
2025-08-27 09:15:04
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5011
  Complete submission text file 0001641172-25-025643.txt   6808
Mailing Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136
Business Address 1951 NW 7TH AVENUE SUITE 520 MIAMI FL 33136 305-302-7158
Longeveron Inc. (Subject) CIK: 0001721484 (see all company filings)

EIN.: 472174146 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-92252 | Film No.: 251260238
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139
Business Address 404 WASHINGTON AVE SUITE 650 MIAMI BEACH FL 33139 786-381-2877
Lincoln Alternative Strategies LLC (Filed by) CIK: 0002043812 (see all company filings)

EIN.: 991727271 | State of Incorp.: DE | Fiscal Year End: 0324
Type: SCHEDULE 13G